Mitochondria-associated ER membranes and Alzheimer disease

Current Opinion in Genetics and Development

Volumn 38, Issue , 2016, Pages 90-96

  Area Gomez, Estela ^a   Schon, Eric A ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; TAU PROTEIN; SECRETASE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BIOCHEMICAL COMPOSITION; BRAIN MITOCHONDRION; CELL COMMUNICATION; CELL FUNCTION; DISEASE COURSE; DISORDERS OF CHOLESTEROL METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROLYTE DISTURBANCE; ENDOPLASMIC RETICULUM MEMBRANE; ENZYME ACTIVITY; HUMAN; METABOLIC DISORDER; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; BRAIN; CELL MEMBRANE; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; BRAIN; CELL MEMBRANE; ENDOPLASMIC RETICULUM; HUMANS; MITOCHONDRIA;

EID: 84969801217     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2016.04.006     Document Type: Review

References (72)

1. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N Eng J Med 2010, 362:329-344.
2. Armstrong R.A., Lantos P.L., Cairns N.J. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?. Neuropathology 2008, 28:351-365.
3. Atwood C.S., Martins R.N., Smith M.A., Perry G. Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins. Peptides 2002, 23:1343-1350.
4. Selkoe D.J. Alzheimer's disease. Cold Spring Harb Perspect Biol 2011, 3:a004457.
5. Holtzman D.M., Herz J., Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Biol 2012, 2:a006312.
6. Huang Y. Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Trends Mol Med 2010, 16:287-294.
7. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
8. Schon E.A., Area-Gomez E. Is Alzheimer's disease a disorder of mitochondria-associated membranes?. J Alzheimers Dis 2010, 20:S281-S292.
9. Schon E.A., Area-Gomez E. Mitochondria-associated E.R. membranes in Alzheimer disease. Mol Cell Neurosci 2013, 55:26-36.
10. Stefani M., Liguri G. Cholesterol in Alzheimer's disease: unresolved questions. Curr Alzheimer Res 2009, 6:15-29.
11. Fraser T., Tayler H., Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 2010, 35:503-513.
12. Hoyer S., Oesterreich K., Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?. J Neurol 1988, 235:143-148.
13. Liu F., Shi J., Tanimukai H., Gu J., Gu J., Grundke-Iqbal I., Iqbal K., Gong C.X. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 2009, 132:1820-1832.
14. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 2001, 26:771-782.
15. Bezprozvanny I., Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 2008, 31:454-463.
16. Wang X., Su B., Zheng L., Perry G., Smith M.A., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 2009, 109:153-159.
17. Area-Gomez E., Schon E.A. Mitochondrial genetics and disease. J Child Neurol 2014, 29:1208-1215.
18. Csordas G., Renken C., Varnai P., Walter L., Weaver D., Buttle K.F., Balla T., Mannella C.A., Hajnoczky G. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 2006, 174:915-921.
19. Hayashi T., Rizzuto R., Hajnoczky G., Su T.P. MAM: more than just a housekeeper. Trends Cell Biol 2009, 19:81-88.
20. Raturi A., Simmen T. Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2013, 1833:213-224.
21. Rusinol A.E., Cui Z., Chen M.H., Vance J.E. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J Biol Chem 1994, 269:27494-27502.
22. Vance D.E., Walkey C.J., Cui Z. Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta 1997, 1348:142-150.
23. Stone S.J., Vance J.E. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J Biol Chem 2000, 275:34534-34540.
24. Prasad M., Kaur J., Pawlak K.J., Bose M., Whittal R.M., Bose H.S. Mitochondria-associated endoplasmic reticulum membrane (MAM) regulates steroidogenic activity via steroidogenic acute regulatory protein (StAR)-voltage-dependent anion channel 2 (VDAC2) interaction. J Biol Chem 2015, 290:2604-2616.
25. 2+ signals into mitochondria. J Biol Chem 2005, 280:40892-40900.
26. 2+ channels. J Cell Biol 2006, 175:901-911.
27. Jia W., Moulson C.L., Pei Z., Miner J.H., Watkins P.A. Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 2007, 282:20573-20583.
28. Friedman J.R., Lackner L.L., West M., DiBenedetto J.R., Nunnari J., Voeltz G.K. ER tubules mark sites of mitochondrial division. Science 2011, 334:358-362.
29. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
30. Simmen T., Aslan J.E., Blagoveshchenskaya A.D., Thomas L., Wan L., Xiang Y., Feliciangeli S.F., Hung C.H., Crump C.M., Thomas G. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J 2005, 24:717-729.
31. Area-Gomez E., de Groof A.J., Boldogh I., Bird T.D., Gibson G.E., Koehler C.M., Yu W.H., Duff K.E., Yaffe M.P., Pon L.A., et al. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol 2009, 175:1810-1816.
32. Newman M., Wilson L., Verdile G., Lim A., Khan I., Moussavi Nik S.H., Pursglove S., Chapman G., Martins R.N., Lardelli M. Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease. Hum Mol Genet 2014, 23:602-617.
33. Schreiner B., Hedskog L., Wiehager B., Ankarcrona M. Amyloid-β peptides are generated in mitochondria-associated endoplasmic reticulum membranes. J Alzheimers Dis 2015, 43:369-374.
34. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., Yan Y., Wang C., Zhang H., Molkentin J.D., et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008, 14:1097-1105.
35. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., Pursglove S.E., Ito A., Winblad B., Cowburn R.F., Thyberg J., et al. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J Biol Chem 2004, 279:51654-51660.
36. Area-Gomez E., Del Carmen Lara Castillo M., Tambini M.D., Guardia-Laguarta C., de Groof A.J.C., Madra M., Ikenouchi J., Umeda M., Bird T.D., Sturley S.L., et al. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J 2012, 31:4106-4123.
37. Hayashi T., Fujimoto M. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction. Mol Pharmacol 2010, 77:517-528.
38. Vetrivel K.S., Cheng H., Lin W., Sakurai T., Li T., Nukina N., Wong P.C., Xu H., Thinakaran G. Association of γ-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 2004, 279:44945-44954.
39. Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., Baki L., Wen P., Efthimiopoulos S., Shao Z., et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002, 21:1948-1956.
40. Csordas G., Varnai P., Golenar T., Roy S., Purkins G., Schneider T.G., Balla T., Hajnoczky G. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell 2010, 39:121-132.
41. Patergnani S., Suski J.M., Agnoletto C., Bononi A., Bonora M., De Marchi E., Giorgi C., Marchi S., Missiroli S., Poletti F., et al. Calcium signaling around mitochondria associated membranes (MAMs). Cell Commun Signal 2011, 9:19.
42. 2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: a review on experimental progress and computational modeling. Biosystems 2015, 134:1-15.
43. Mattson M.P. ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 2010, 3:pe10.
44. Supnet C., Bezprozvanny I. Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. J Alzheimers Dis 2010, 20(Suppl 2):S487-S498.
45. Gibson G.E., Vestling M., Zhang H., Szolosi S., Alkon D., Lannfelt L., Gandy S., Cowburn R.F. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol Aging 1997, 18:573-580.
46. Peterson C., Goldman J.E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A 1986, 83:2758-2762.
47. Sims N.R., Finegan J.M., Blass J.P. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann Neurol 1987, 21:451-457.
48. Sun S., Zhang H., Liu J., Popugaeva E., Xu N.-J., Feske S., White C.L., Bezprozvanny I. Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice. Neuron 2014, 82:79-93.
49. Cho D.-H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
50. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenerg Biomembr 2009, 41:425-431.
51. Gibson G.E., Huang H.-M. Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases. J Bioenerg Biomembr 2004, 36:335-340.
52. Riemer J., Kins S. Axonal transport and mitochondrial dysfunction in Alzheimer's disease. Neurodegener Dis 2013, 12:111-124.
53. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
54. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 2008, 105:19318-19323.
55. Young-Collier K.J., McArdle M., Bennett J.P. The dying of the light: mitochondrial failure in Alzheimer's disease. J Alzheimers Dis 2012, 28:771-781.
56. Flis V.V., Daum G. Lipid transport between the endoplasmic reticulum and mitochondria. Cold Spring Harb Perspect Biol 2013, 5:a013235.
57. Voelker D.R. Bridging gaps in phospholipid transport. Trends Biochem Sci 2005, 30:396-404.
58. Puglielli L., Konopka G., Pack-Chung E., Ingano L.A., Berezovska O., Hyman B.T., Chang T.Y., Tanzi R.E., Kovacs D.M. Acyl-coenzyme A:cholesterol acyltransferase modulates the generation of the amyloid β-peptide. Nat Cell Biol 2001, 3:905-912.
59. Feng B., Yao P.M., Li Y., Devlin C.M., Zhang D., Harding H.P., Sweeney M., Rong J.X., Kuriakose G., Fisher E.A., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 2003, 5:781-792.
60. Gómez-Ramos P., Asunción Morán M. Ultrastructural localization of intraneuronal Aβ-peptide in Alzheimer disease brains. J Alzheimers Dis 2007, 11:53-59.
61. Pani A., Dessì S., Diaz G., La Colla P., Abete C., Mulas C., Angius F., Cannas M.D., Orru C.D., Cocco P.L., et al. Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease. J Alzheimers Dis 2009, 18:829-841.
62. Puglielli L., Ellis B.C., Ingano L.A., Kovacs D.M. Role of acyl-coenzyme A:cholesterol acyltransferase activity in the processing of the amyloid precursor protein. J Mol Neurosci 2004, 24:93-96.
63. Tambini M.D., Pera M., Kanter E., Yang H., Guardia-Laguarta C., Holtzman D., Sulzer D., Area-Gomez E., Schon E.A. ApoE4 upregulates the activity of mitochondria-associated ER membranes. EMBO Rep 2016, 17:27-36.
64. Heeren J., Grewal T., Laatsch A., Rottke D., Rinninger F., Enrich C., Beisiegel U. Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J Biol Chem 2003, 278:14370-14378.
65. Heeren J., Grewal T., Laatsch A., Becker N., Rinninger F., Rye K.-A., Beisiegel U. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem 2004, 279:55483-55492.
66. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 2008, 9:125-138.
67. Wollmer M.A. Cholesterol-related genes in Alzheimer's disease. Biochim Biophys Acta 2010, 1801:762-773.
68. Steinberg S., Stefansson H., Jonsson T., Johannsdottir H., Ingason A., Helgason H., Sulem P., Magnusson O.T., Gudjonsson S.A., Unnsteinsdottir U., et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet 2015, 47:445-447.
69. Abe-Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K.-i., Ueda K., Yokoyama S. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem 2004, 279:604-611.
70. 42/43 peptide by γ-secretase can be inhibited directly by modulation of membrane thickness. J Biol Chem 2012, 287:21326-21334.
71. Perl D.P. Neuropathology of Alzheimer's disease. Mt Sinai J Med 2010, 77:32-42.
72. Yoshikane H., Nihei T., Moriyama K. Three-dimensional observation of intracellular membranous structures in dog heart muscle cells by scanning electron microscopy. J Submicrosc Cytol 1986, 18:629-636.